Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China
ConclusionsThese EHDs provide potential value to post-marketing drug safety surveillance and pharmacoepidemiology in China. Future research is warranted to assess the quality and completeness of these EHDs or additional data sources in China.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Academia | China Health | Databases & Libraries | Drugs & Pharmacology | Electronic Medical Records (EMR) | Study